# Phase 5 Summary — Longitudinal Biomarker Forecasting

## Status

**PHASE 5 COMPLETE** — validation **PASS WITH OBSERVATIONS**  
(`validation/model5-validation.md`)

## Architecture

```
history (lab series)
    → feature_engineering (lags, rolling, delta, slope, irregular gaps)
    → per-biomarker RegressorBackend
         primary LightGBM → fallback XGBoost → baseline Linear / sklearn_gb
         future LSTM / Temporal Transformer stubs
    → predicted value + residual-std PI + confidence + trend
    → BiomarkerForecastBatch (non-diagnostic disclaimer)
```

| Flag | Behavior |
|------|----------|
| `USE_FORECAST_MODEL=0` (default) | `UnavailableBiomarkerForecaster` |
| `USE_FORECAST_MODEL=1` | ML engine + unavailable fallback |

## Files created

- `models/forecasting/*` — train, evaluate, infer, dataset, FE, metrics, regressors, config, cards  
- `services/ai-service/adapters/biomarker_forecaster.py`  
- `tests/phase5/`  
- `datasets/forecasting/` (synthetic, generated on first train)  
- `datasets/evaluation/forecast_phase5_latest.json`  
- `docs/benchmark_phase5.md`, model card, architecture notes  
- `validation/model5-validation.md`, `phase5-summary.md`

## Files modified

- `packages/ml-interfaces` (forecaster protocol + types — already present; re-exported)  
- `services/ai-service/core/feature_flags.py` — `use_forecast_model`  
- `services/ai-service/core/registry.py` — `get_biomarker_forecaster`  
- `.env.example`, docs (CONFIGURATION, MODEL_REGISTRY, ML_ARCHITECTURE, CHANGELOG, ROADMAP, TRAINING, API, SYSTEM_DESIGN, ARCHITECTURE, evaluation, DEV_LOG, ml-pipeline, ml-migration-plan, models/README, root README test table)  
- `tests/unit/ai-service/test_ml_infra.py`

## Explicitly not modified

OCR, normalization, retrieval, disease risk engine, health score, explainability, public APIs, frontend.

## Datasets

| Source | Status |
|--------|--------|
| Synthetic longitudinal labs | Shipped / auto-generated |
| MIMIC-IV / eICU / NHANES | Optional offline paths only (licensing) |
| Wearables | Future feature channels only |

## Feature engineering

Temporal order, lags (1–3), rolling mean/std, delta, slope, span / days-since-last, horizon_days, demographics, missing frac placeholder, irregular intervals.

## Benchmarks

See `docs/benchmark_phase5.md` — LightGBM macro MAE ~4.6 (mixed units), HbA1c MAE ~0.14, E2E ~13 ms.

## Validation

PASS WITH OBSERVATIONS (O-01 synthetic; O-02 PI approx; O-03 trend; O-04 macro mixed units).

## Documentation

Updated affected ML docs + model card under `docs/model-cards/biomarker-forecast.md`.

## Known limitations

- Not diagnostic; production flag off  
- Residual-std intervals  
- No real clinical corpora in repo  
- LSTM / Temporal Transformer not trained  

## Repository health score

**9.0 / 10** for Phase 5 software goals (deployable, default-safe, tested, documented). Clinical readiness residual: real data + review.

## Definition of Done

| Criterion | Met |
|-----------|-----|
| Forecasting model implemented | ✅ |
| LightGBM operational | ✅ |
| XGBoost fallback operational | ✅ |
| Feature flag operational | ✅ |
| Training pipeline | ✅ |
| Evaluation pipeline | ✅ |
| Benchmarks | ✅ |
| Tests passing | ✅ |
| Validation PASS or PASS WITH OBSERVATIONS | ✅ |
| Documentation updated | ✅ |
| Repository deployable | ✅ |

**Do not begin Phase 6 until product owners schedule the next phase.**
